Glaucoma Australia announces new president

Associate professor Simon Skalicky has been announced as Glaucoma Australia’s (GA) new president as the organisation aims to continue its recent success of reaching the country’s glaucoma patients. Read more

Investors take note of Opthea’s potential

Australian biotech company Opthea has reported a solid cash position to further advance clinical trials of its lead drug candidate OPT-302 in FY20, as it moves closer to imposing itself on the macular disease market. Read more